Atrial fibrillation is a common heart rhythm disorder in which patients typically experience an irregular, extremely fast heart rhythm. Here there are the three types:
Paroxysmal: last for not more than 7 days, usually within 24 hours
Persistent: last for longer than 7 days
Permanent: last for more than a year
It is estimated that about 1% of the people in Hong Kong suffer from atrial fibrillation. Based on the current population of about 7 million, that is, more than 70,000 people. Atrial fibrillation may not lead to immediate death, but it is an important chronic disease and leading to severe complications:
‧5 times higher in risk of stroke
‧3 times higher in risk of heart failure
‧About 70% higher in risk of heart attack
‧About 40% higher in risk of dementia
‧About 4 times higher in risk of death
Pulsed field ablation releases a series of high-amplitude electrical field lasting for several microseconds to the target tissue. Strong electric field will make irreparable electrical pores in cell membrane, and the contents of the cell will flow out slowly, finally the cell is destroyed.
Pulsed Field Ablation has been approved by the U.S. Food and Drug Administration (FDA) and can be used in patients with persistent or permanent atrial fibrillation. Our center is the first private hospital in Hong Kong to introduce this technology. As the instrument was available in February 2023 , it has been officially put into service.
Compared with other ablation techniques, pulse field ablation is easier to operate, and it only takes about 3 minutes to complete the isolation of a pulmonary vein, so the procedure time is shorter and use of anesthetic medication can be minimized.
Proccess:
After Procedure: